Alaris System Named 2015 Best In KLAS for Smart Pumps

Feb 24, 2016

FRANKLIN LAKES, N.J., Feb. 24, 2016 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the Alaris System has been named 2015 Best in KLAS for Smart Pumps in the 2015 Best in KLAS: Medical Equipment report.

The 2015 Best in KLAS: Medical Equipment report states that providers believe that BD is better positioned for the future in regard to interoperability with electronic medical records (EMRs), and customers appreciate the added benefit of having patient-controlled analgesia (PCA) and syringe modules for the same pump. In addition, the report stated that consistent customer service is another advantage for BD customers, and all other large volume pump (LVP) vendors struggle more to provide support to clients.

KLAS is an organization that independently monitors health care information technology performance through the active participation of thousands of health care organizations. Earlier this year, the Alaris System was rated as the industry leader for interoperability with EMRs in the Smart Pump/EMR Integration report released from KLAS.

"We are proud to receive Best in KLAS honours for the Alaris System," said J.C. Kyrillos, worldwide vice president and general manager for Infusion Solutions for BD. "We continue to invest in innovation to maintain our technical leadership for infusion solutions that help clinicians deliver safer and more efficient care."

The Alaris System is a "smart" IV pump that contains advanced technology and software to notify clinicians when an infusion is outside of the normal range, which helps avoid infusion medication errors. The Alaris System features a unique modular design that combines a single point-of-care unit featuring Guardrails Suite MX safety software with large volume pump(s), patient controlled analgesia (PCA), respiratory monitoring through end-tidal carbon dioxide (EtCO2) and/or, pulse oximetry measurement of oxygen saturation (SpO2), syringe and barcoding capabilities to help protect every type of infusion.

The Alaris System can be wirelessly pre-populated with infusion order parameters directly from the hospital’s EHR. Instead of manually programming the pump using the keypad, the pump is pre-populated with the patient's medication order after scanning the barcodes on the patient's ID band, on the medication to be administered and on the smart pump. Automatically programming the pump with the patient's medication order from the verified physician order in the EHR helps ensure accurate IV medication administration and documentation, and reduces opportunities for human error.

About BD

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.

For more information on BD, please visit

Troy Kirkpatrick

858 617 2361
Email Troy

Monique N. Dolecki

201 847 5378

Back to News Releases

Please note, products and services mentioned may not be licensed/available in Canada. Please check with your local BD representative.


This site uses cookies. If you click accept cookies then all cookies will be written. Please review our cookies policy and configure your cookies for your experience.